Search

Displaying results 6941 - 6950 of 10000 in total
  1. Target

    4-hydroxyphenylpyruvate dioxygenase

    go.drugbank.com/bio_entities/BE0000455
    TargetHumans

    Catalyzes the conversion of 4-hydroxyphenylpyruvic acid to homogentisic acid, one of the steps in tyrosine catabolism (PubMed:10942115, PubMed:1339442, PubMed:34047349, PubMed:37794595).

    Polypeptides: 4-hydroxyphenylpyruvate dioxygenaseSynonyms: 4-hydroxyphenylpyruvic acid oxidase
  2. Target

    Integrin alpha-4

    go.drugbank.com/bio_entities/BE0000590
    TargetHumans

    Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are receptors for fibronectin. They recognize one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. … ITGA4:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1

    Polypeptides: Integrin alpha-4Synonyms: VLA-4 subunit alpha
  3. Target

    Integrin beta-4

    go.drugbank.com/bio_entities/BE0003298
    TargetHumans

    Integrin alpha-6/beta-4 is a receptor for laminin. Plays a critical structural role in the hemidesmosome of epithelial cells. Is required for the regulation of keratinocyte polarity and motility.

    Polypeptides: Integrin beta-4
  4. Target

    4-hydroxymandelate synthase

    go.drugbank.com/bio_entities/BE0004115
    TargetAmycolatopsis orientalis

    Required to synthesize hydroxyphenylglycine, a recurring skeletal component of nonproteinogenic macrocyclic peptide antibiotics such as vancomycin. Catalyzes the conversion of p-hydroxyphenylpyruvate to p-hydroxymandelate. The decarboxyl...

    Polypeptides: 4-hydroxymandelate synthaseSynonyms: 4-hydroxyphenylpyruvate dioxygenase II
  5. Target

    Phosphodiesterase isozyme 4

    go.drugbank.com/bio_entities/BE0009697
    TargetHumans

    Polypeptides: Phosphodiesterase isozyme 4Function: 3',5'-cyclic-AMP phosphodiesterase activity
  6. Target

    P2Y purinoceptor 4

    go.drugbank.com/bio_entities/BE0009822
    TargetHumans

    Receptor for UTP and UDP coupled to G proteins that activate a phosphatidylinositol-calcium second messenger system. Not activated by ATP or ADP

    Polypeptides: P2Y purinoceptor 4
  7. Target

    Prolyl 4-hydroxylase

    go.drugbank.com/bio_entities/BE0009980
    EnzymeHumans

    Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins … Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins

    Polypeptides: Prolyl 4-hydroxylase subunit alpha-2, Prolyl 4-hydroxylase subunit alpha-1Synonyms: 4-PH alpha-2, Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2
  8. Drug

    Carmoterol

    go.drugbank.com/drugs/DB15784
    Investigational

    Mixtures: POENA 4/400 MCG INHALASYON IÇIN TOZ IÇEREN BLISTER ,60 DOZ, POENA 4/400 MCG INHALASYON IÇIN TOZ IÇEREN KAPSÜL, 60 KAPSÜLCategories: Heterocyclic Compounds, 2-Ring
  9. Drug

    Strontium ranelate

    go.drugbank.com/drugs/DB09267
    ApprovedWithdrawn

    Available for prescription use for a time in some parts of the world as Protelos (strontium ranelate) 2 g granules for oral suspension by Servier, it was ultimately discontinued in 2016-2017 owing to an … Strontium ranelate, a strontium (II) salt of ranelic acid, is a medication for osteoporosis.

    Mixtures: FULLBONE D3 2 G/800 IU EFERVESAN TABLET, 30 ADET, FULLBONE D3 2 G/800 IU EFERVESAN TABLET, 60 ADETCategories: Heterocyclic Compounds, 1-Ring
  10. Drug

    Medronic acid

    go.drugbank.com/drugs/DB14078
    ApprovedInvestigational

    Products: MON MDP KIT 10 MG IV ENJEKSİYON İÇİN LİYOFİLİZE TOZ İÇEREN FLAKON, 5 ADET, DRAXIMAGE® MDP